Dr. Cynthia Golomb is triple board certified in Dermatology, Dermatopathology and Micrographic Dermatologic Surgery (Mohs).
She attended medical school at the University of Miami, Miller School of Medicine, earned a certificate of internship at the University of Colorado and completed her dermatology residency at the University of Miami – Jackson Memorial Hospital.
After receiving her board certification in dermatology, she completed a dermatopathology fellowship at Roger Williams Hospital/Boston University. Dr. Golomb served on the faculty as an assistant professor at Boston University School of Medicine. She also played a key role in developing the residency program for the department of dermatology and skin surgery at Roger Williams Hospital, Providence Rhode Island.
Dr. Golomb earned a bachelor of science degree in pharmacy from the University of Pittsburgh and practiced as a registered pharmacist in Pennsylvania and Florida prior to attending medical school.
Dr. Golomb is a fellow member of the American Academy of Dermatology, American Society of MOHS Surgery and American Society of Dermatopathology. She is a member of the American Medical Association and Florida Society of Dermatology and Dermatologic Surgery. She served as Secretary/Treasurer and Past President of Miami-Dade Dermatologic Society. Dr. Golomb served as a voluntary associate professor in the department of dermatology at the University of Miami, Miller School of Medicine for more than 12 years.
During her medical career, she has been involved in research studies and presented her findings at scientific meetings in the United States and Europe. Dr. Golomb traveled to Central America to work closely with an indigenous population of the San Blas Islands who suffered from skin disorders.
Dr. Cynthia Golomb doing research on a skin substitute for use in skin grafting.
Dr. Golomb has been an investigator in clinical trials for a number of medical devices and biologic products including a skin substitute to enhance wound healing, aminolevulonic acid and photodynamic therapy for the treatment of actinic keratosis. She served as a sub-investigator on clinical trials for Restylane® and Dysport® prior to FDA approval in the United States.
Stay in the know…
Sign up to receive skin care tips and news to improve your health
and appearance from Dr. Cynthia Golomb. The newsletter is sent
approximately monthly and you can unsubscribe at any time.
Get in the know and sign up for emails from Cynthia Golomb, MD.
